Senior insider sale
General Counsel at NURIX THERAPEUTICS, INC. — senior position signals high conviction
$768.4K
47.31K shares
What this filing means
RING CHRISTINE plans to sell 47.31K shares of NURIX THERAPEUTICS, INC. valued at approximately $768.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/4/2026ACC: 0001950047-26-003985
Officer· General Counsel
Since Jul 2020
47.31K
Shares to sell
$768.4K
Approx. market value
8.15K
Acquired (3 months)
1
Planned
6 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
5/2/2022
8.15KTotal acquired8.15K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/2/2022 | Restricted Stock Units N/A | 8.15K | — |
| Total | 8.15K | ||
Planned & Completed Dispositions7
Completed
—Completed
Units to sell
5.39K
Market value
$90.4K
5/1/2026
—Completed
Units to sell
3.21K
Market value
$53.5K
4/30/2026
—Completed
Units to sell
8.15K
Market value
$124.1K
4/2/2026
—Completed
Units to sell
8.15K
Market value
$125.8K
3/2/2026
—Completed
Units to sell
6.11K
Market value
$101.9K
2/9/2026
—Completed
Units to sell
8.15K
Market value
$135.8K
2/9/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
8.15K
Market value
$137.0K
5/4/2026
Total
Units
47.31K
Value
$768.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/1/2026 | 5.39K | $90.4K | — | Completed |
4/30/2026 | 3.21K | $53.5K | — | Completed |
4/2/2026 | 8.15K | $124.1K | — | Completed |
3/2/2026 | 8.15K | $125.8K | — | Completed |
2/9/2026 | 6.11K | $101.9K | — | Completed |
2/9/2026 | 8.15K | $135.8K | — | Completed |
| Planned — Approximate Date | ||||
5/4/2026 | 8.15K | $137.0K | NASDAQ | Planned |
| Total | 47.31K | $768.4K | ||